COL15A1
protein-codingcollagen type XV alpha 1 chain, the group of Collagen proteoglycans|Collagens
Gene summary
This gene encodes the alpha chain of type XV collagen, a member of the FACIT collagen family (fibril-associated collagens with interrupted helices). Type XV collagen has a wide tissue distribution but the strongest expression is localized to basement membrane zones so it may function to adhere basement membranes to underlying connective tissue stroma. The proteolytically produced C-terminal fragment of type XV collagen is restin, a potentially antiangiogenic protein that is closely related to endostatin. Mouse studies have shown that collagen XV deficiency is associated with muscle and microvessel deterioration. [provided by RefSeq, May 2013]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~127.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to COL15A1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001855.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 17 | 5 | 24 | ||
| missense | 219 | 18 | 17 | 254 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 20 | 20 | ||||
| Total | 0 | 0 | 243 | 35 | 22 | 300 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001846.3 | 42 | MANE Select | |
| Ensembl | ENSP00000364140.3 | 42 | MANE Select | |
| Ensembl | ENSP00000543278.1 | 42 | Standard | |
| Ensembl | ENSP00000543278.1 | 42 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| col15a1a | Danio rerio | Structure: primary motor neuron Quality: decreased length abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Protein digestion and absorption - Homo sapiens (human)
- Assembly of collagen fibrils and other multimeric structures
- Collagen chain trimerization
- Collagen biosynthesis and modifying enzymes
- Collagen formation
Biological Process
- angiogenesis
- cell adhesion
- signal transduction
- cell differentiation
- extracellular matrix organization
Molecular Function
- extracellular matrix structural constituent
- extracellular matrix structural constituent conferring tensile strength
Cellular Component
- extracellular region
- collagen type XV trimer
- extracellular space
- endoplasmic reticulum lumen
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000375001
- Coding exons
- 42
- Length
- 127609
- Individuals with no LoFs
- 125183
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 564
- Defined
- 125748
- p
- 0.00225
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.120 | 798 | 808 | 0.988 | 0.0000437 | 8846 |
| Missense (PolyPhen) | 296 | 311.87 | 0.94912 | 3253 | ||
| Synonymous | -0.898 | 341 | 321 | 1.06 | 0.0000202 | 2952 |
| Loss of Function | 5.05 | 27 | 73.8 | 0.366 | 0.00000372 | 866 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0013 | 0.0012 | notable |
| Latino/Admixed American | 0.0014 | 0.0014 | notable |
| Ashkenazi Jewish | 0.0079 | 0.0080 | notable |
| East Asian | 0.00088 | 0.00087 | rare |
| Finnish | 0.0018 | 0.0018 | notable |
| European (Non-Finnish) | 0.0018 | 0.0018 | notable |
| South Asian | 0.0046 | 0.0046 | notable |
| Other | 0.0028 | 0.0028 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Structural protein that stabilizes microvessels and muscle cells, both in heart and in skeletal muscle. {ECO:0000269|PubMed:10049780}.;
Intolerance Scores
- LoFtool
- 0.0931
- RVIS EVS
- 1.84
- RVIS percentile EVS
- 97.1
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0880
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |